S-adenosyl-methionine-dependent methyltransferases: highly versatile enzymes in biocatalysis, biosynthesis and other biotechnological applications
FDA has already approved this IDH1 inhibitor for patients with refractory acute myeloid leukemia (AML) who have IDH1 mutation(s) as a candidate drug to be tested in combination with bipolar antiandrogen therapy [45]
Braak, H., Rb, U., Jansen Steur, E
Their amphiphilic nature, characterized by a hydrophobic core and a hydrophilic surface, enables them to carry a wide range of therapeutic agents, making them effective vaccine delivery systems [87]
It's an immune regulator, part of the body's defense system
Extension of the native insulin-like growth factor-1 sequence by 13 amino acids and substitution of glutamic acid-3 with arginine produced a structurally distinct analogue central to IGF-1 receptor signalling studies